IR@PKUHSC  > 北京大学临床肿瘤学院  > 肿瘤放疗科
学科主题临床医学
Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer
Guo, Jianping; Shou, Chengchao; Meng, Lin; Jiang, Beihai; Bin Dong; Yao, Lihua; Xie, Yuntao; Zhang, Jianzhi; Chen, Yiding; Budman, Daniel R.; Shi, Yuenian Eric
关键词synuclein gamma breast cancer prognosis chaperone protein
刊名INTERNATIONAL JOURNAL OF CANCER
2007-09-15
DOI10.1002/ijc.22763
121期:6页:1296-1305
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]ESTROGEN-RECEPTOR ; ALPHA-SYNUCLEIN ; ABERRANT EXPRESSION ; ALZHEIMER-DISEASE ; GENE ; METASTASIS ; PROMOTES ; CELLS ; IDENTIFICATION ; STIMULATION
英文摘要

Synuclein 7 (SNCG), previously identified as a breast cancer-specific gene (BCSG1), is highly expressed in breast carcinomas but not in normal epithelium. SNCG regulates many pathways in growth and progression of breast cancer. To determine if SNCG is a biomarker for clinical prognosis of breast cancer, we generated a panel of murine monoclonal antibodies (mAbs) against human SNCG and correlated SNCG protein expression in 358 clinical breast cancer specimens with clinical outcome. A panel of 14 mAbs was characterized by ELISA, immunoprecipitation (IP), Western blot, immunocytochemistry and immunohistochemistry. SNCG protein expression was determined in 438 clinical breast specimens by immunohistochemical analysis using mAb 5C5. Expression of SNCG was strongly correlated with the stage, lymph node involvement, metastasis, tumor size and Her-2 status, but its expression was not associated with ER and PR expression status. While 71.4% of advanced breast cancers were positive for SNCG expression, only 26.8% of Stage I/II breast cancers were positive for SNCG expression and 5.2% of benign hyperplasia expressed SNCG. SNCG protein was not detectable in normal tissue adjacent to breast cancer. After a median follow-up of 64 months, patients with an SNCG-positive tumor had a significfintly shorter disease-free survival and overall survival and a high probability of death compared no expression of SNCG. Multivariate analysis demonstrated that SNCG was a strong independent prognostic variable. SNCG is a new unfavorable prognostic marker for breast cancer progression and a potential target for breast cancer treatment. (c) 2007 Wiley-Liss, Inc.

语种英语
WOS记录号WOS:000248976800017
引用统计
被引频次:39[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/64843
专题北京大学临床肿瘤学院_肿瘤放疗科
作者单位1.Peking Univ, Sch Oncol, Beijing Canc hosp & inst, Dept Radiat Oncol, Beijing 100871, Peoples R China
2.Albert Einstein Coll Med, N Shore Long Island Jewish Hlth Syst, Feinstein Inst Med Res, Bronx, NY 10467 USA
推荐引用方式
GB/T 7714
Guo, Jianping,Shou, Chengchao,Meng, Lin,et al. Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer[J]. INTERNATIONAL JOURNAL OF CANCER,2007,121(6):1296-1305.
APA Guo, Jianping.,Shou, Chengchao.,Meng, Lin.,Jiang, Beihai.,Bin Dong.,...&Shi, Yuenian Eric.(2007).Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer.INTERNATIONAL JOURNAL OF CANCER,121(6),1296-1305.
MLA Guo, Jianping,et al."Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer".INTERNATIONAL JOURNAL OF CANCER 121.6(2007):1296-1305.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Guo, Jianping]的文章
[Shou, Chengchao]的文章
[Meng, Lin]的文章
百度学术
百度学术中相似的文章
[Guo, Jianping]的文章
[Shou, Chengchao]的文章
[Meng, Lin]的文章
必应学术
必应学术中相似的文章
[Guo, Jianping]的文章
[Shou, Chengchao]的文章
[Meng, Lin]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。